Skip to main content
Frontiers in Pharmacology logoLink to Frontiers in Pharmacology
. 2016 Jun 29;7:199. doi: 10.3389/fphar.2016.00199

Retraction: Mechanism of Action of the Novel Nickel(II) Complex in Simultaneous Reactivation of the Apoptotic Signaling Networks Against Human Colon Cancer Cells

Frontiers in Pharmacology Editorial Office*
PMCID: PMC4926803  PMID: 27445829

The Journal and Authors retract the 28 January 2016 article cited above for the following reasons: Following online criticisms of the published paper, an investigation at the journal has confirmed the manipulation and duplication of data, and a level of image processing that is not compliant with the journal’s policies on image data integrity.

Further, a post-publication cross-check screening revealed significant overlap with another manuscript submitted by the authors to another journal. While all manuscripts submitted to Frontiers undergo cross-check screening, the article cited below was in review in parallel with the Frontiers article and thus the overlap was not apparent until publication (Samie et al., 2016).

References

  1. Samie N., Muniandy S., Kanthimathi M. S., Haerian B. S. (2016). Mechanism of action of novel piperazine containing a toxicant against human liver cancer cells. PeerJ. 4:e1588. 10.7717/peerj.1588 [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]

Articles from Frontiers in Pharmacology are provided here courtesy of Frontiers Media SA

RESOURCES